Borgeson Blake 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Award
Class A Common Stock
2024-07-01+1,441→ 7,178,557 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.